Percentage of patients with PCR-positive nasopharyngeal samples from inclusion to day6 post-inclusion in COVID-19 patients treated
with hydroxychloroquine only, in COVID-19 patients treated with hydroxychloroquine and azithomycin combination, and in COVID-19 control patients.
Here is the original text on the results obtained in France in the treatment of covid-19 with the use of a combination of hydrochloroquinine and azitomycin and the video in which they are explained.
For more information
IHU Méditerranée Infection
Hydroxychloroquine and azithromycin as a treatment of COVID-19
Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949
This post is also available in: Italian